封面
市场调查报告书
商品编码
1547503

全球医用酵素技术市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Medical Enzyme Technology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

全球医用酵素技术市场需求预计将从2023年的60.8亿美元达到2032年近109.3亿美元的市场规模,2024-2032年研究期间复合年增长率为6.74%。

酵素在动物、植物、人类以及微生物的代谢活动中发挥关键作用。因此,它们在微生物生物技术和诊断过程中具有广泛的用途。酵素透过三种作用机转发挥作用:打破内部血栓、溶解血管壁硬化、溶解伤口肿胀以促进癒合。因此,酵素可以用作治疗一系列疾病的药物,例如胰蛋白酶用于加速伤口癒合、溶解血栓、去除坏死组织以及抑制污染微生物的增殖。此外,具有抗发炎作用的蛋白酶可用于治疗消化不良。此外,脂肪酶、豆粕纤溶酶、超氧化物歧化酶、纳豆激酶、凝血酶等可用于治疗多种疾病。

市场动态

随着酵素在疾病预防和治疗中的应用不断增加,对开发先进酵素工程技术的投资不断增加,以及生物催化剂在医疗领域的广泛应用带来的指数级增长,全球医用酵素技术市场预计将蓬勃发展。透过广泛的研究,医用酵素正在探索其在医疗器材清洁、代谢辅助、药物传递、疾病诊断和药物製造方面的重要性。目前,科学家和研究人员正在集中精力解决传统医用酵素技术的缺陷,这将在未来几年重新定义医用酵素技术市场。此外,人们正在做出许多努力来增强医用级酶的热稳定性和其他性能,这有望改善全球市场的整体前景。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球医用酵素技术市场的各个细分市场进行了包容性评估。医用酵素技术产业的成长和趋势为本研究提供了整体方法。

市场区隔

医用酶技术市场报告的这一部分提供了国家和区域级别细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

依酶类型

  • 消化酵素
  • 水解酶
  • 溶栓酶

按申请

  • 疾病治疗
  • 诊断工具
  • 生物医学研究

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲医用酶技术市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。医用酵素技术市场的主要参与者包括 Thermo Fisher Scientific Inc.、Asahi Kasei Corporation、Merck KgaA、Agilent Technologies Inc.、Novozymes A/S、Promega Corporation、Takeda Pharmaceutical Company Limited、Amano Enzyme Inc.、Sun Pharmaceutical Industries Ltd . ,丹纳赫公司。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:医用酵素技术 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按酶类型分類的市场吸引力分析
    • 市场吸引力分析:依应用分类
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球医用酵素技术市场分析:按酵素类型

  • 按酶类型概述
  • 按酶类型进行历史和预测数据分析
  • 消化酵素
  • 水解酶
  • 溶栓酶

第 6 章:全球医用酵素技术市场分析:依应用分类

  • 概述:按应用
  • 历史与预测资料分析:按应用分类
  • 疾病治疗
  • 诊断工具
  • 生物医学研究

第 7 章:全球医用酵素技术市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第8章:医用酵素技术公司的竞争格局

  • 医用酵素技术市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Asahi Kasei Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merck KgaA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Agilent Technologies Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Novozymes A/S
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Promega Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Takeda Pharmaceutical Company Limited
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Amano Enzyme Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Sun Pharmaceutical Industries Ltd.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Danaher Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR11215141

The global demand for Medical Enzyme Technology Market is presumed to reach the market size of nearly USD 10.93 Billion by 2032 from USD 6.08 Billion in 2023 with a CAGR of 6.74% under the study period 2024-2032.

Enzymes play a critical part in the metabolic activities of animals, plants, humans, as well as microbial. Thus, they have a wide range of uses in microbial biotechnology and diagnosis processes. Enzymes serve to be effective with three action mechanisms: breaking the internal blood clots, dissolving the hardening of walls of blood vessels, and dissolving the wound swelling to promote healing. Thus, enzymes can be used as medicines to treat a range of diseases, such as trypsin used to accelerate wound healing, dissolve blood clots, remove necrotic tissue, and inhibit the proliferation of contaminating microorganisms. In addition, a protease with an anti-inflammatory effect can be used to treat dyspepsia. Moreover, lipase, soybean meal plasmin, superoxide dismutase, nattokinase, and thrombin, among others, can be used to treat various diseases.

MARKET DYNAMICS

The global medical enzyme technology market is anticipated to thrive with escalating adoption of enzymes for disease prevention and treatment, mounting investments toward developing advanced enzyme engineering technologies, and exponential growth due to the broad application of biocatalysts in the medical sector. The medical enzyme is exploring its significance across medical device cleaning, metabolism assistance, drug delivery, disorders diagnosis, and manufacturing of medicines through extensive research. Presently, scientists and researchers are concentrating on addressing the shortcoming of traditional medical enzyme technologies, which is attributed to redefine the medical enzyme technology market in coming years. In addition, many efforts are being made to enhance thermo-stability and other properties of medical-grade enzymes, which are expected to improve the overall prospects of the global market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Medical Enzyme Technology. The growth and trends of Medical Enzyme Technology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Medical Enzyme Technology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Enzyme Type

  • Digestive Enzymes
  • Hydrolases
  • Thrombolytic Enzymes

By Application

  • Disease Treatment
  • Diagnostic Tools
  • Biomedical Research

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Medical Enzyme Technology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Enzyme Technology market include Thermo Fisher Scientific Inc., Asahi Kasei Corporation, Merck KgaA, Agilent Technologies Inc., Novozymes A/S, Promega Corporation, Takeda Pharmaceutical Company Limited, Amano Enzyme Inc., Sun Pharmaceutical Industries Ltd., Danaher Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. MEDICAL ENZYME TECHNOLOGY - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Enzyme Type
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL MEDICAL ENZYME TECHNOLOGY MARKET ANALYSIS BY ENZYME TYPE

  • 5.1. Overview By Enzyme Type
  • 5.2. Historical and Forecast Data Analysis By Enzyme Type
  • 5.3. Digestive Enzymes Historic and Forecast Sales By Regions
  • 5.4. Hydrolases Historic and Forecast Sales By Regions
  • 5.5. Thrombolytic Enzymes Historic and Forecast Sales By Regions

6. GLOBAL MEDICAL ENZYME TECHNOLOGY MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Disease Treatment Historic and Forecast Sales By Regions
  • 6.4. Diagnostic Tools Historic and Forecast Sales By Regions
  • 6.5. Biomedical Research Historic and Forecast Sales By Regions

7. GLOBAL MEDICAL ENZYME TECHNOLOGY MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE MEDICAL ENZYME TECHNOLOGY COMPANIES

  • 8.1. Medical Enzyme Technology Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF MEDICAL ENZYME TECHNOLOGY INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Thermo Fisher Scientific Inc.
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Asahi Kasei Corporation
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Merck KgaA
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Agilent Technologies Inc.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Novozymes A/S
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Promega Corporation
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Takeda Pharmaceutical Company Limited
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Amano Enzyme Inc.
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Sun Pharmaceutical Industries Ltd.
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Danaher Corporation
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Enzyme Type (USD MN)
  • Digestive Enzymes Market Sales By Geography (USD MN)
  • Hydrolases Market Sales By Geography (USD MN)
  • Thrombolytic Enzymes Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Disease Treatment Market Sales By Geography (USD MN)
  • Diagnostic Tools Market Sales By Geography (USD MN)
  • Biomedical Research Market Sales By Geography (USD MN)
  • Global Medical Enzyme Technology Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Medical Enzyme Technology Report
  • Market Research Process
  • Market Research Methodology
  • Global Medical Enzyme Technology Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Enzyme Type
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Enzyme Type (USD MN)
  • Digestive Enzymes Market Sales By Geography (USD MN)
  • Hydrolases Market Sales By Geography (USD MN)
  • Thrombolytic Enzymes Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Disease Treatment Market Sales By Geography (USD MN)
  • Diagnostic Tools Market Sales By Geography (USD MN)
  • Biomedical Research Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.